logo
#

Latest news with #BarkhaMathur

France to ban smoking in public spaces where kids are present from July 1
France to ban smoking in public spaces where kids are present from July 1

Business Standard

timea day ago

  • Health
  • Business Standard

France to ban smoking in public spaces where kids are present from July 1

Starting July 1, France will ban smoking in public spaces like parks, beaches, and bus stops to protect children's health; violators may face fines up to 135 euros ($154) Barkha Mathur New Delhi France is saying 'non' to puffing in public where children are around. Starting this July, lighting up a cigarette at the beach or bus stop in France might land you a hefty fine. In a move hailed by health advocates, the French government is set to roll out tough new anti-smoking rules to keep public spaces, especially those frequented by children, smoke-free, according to media reports. Why is France banning smoking in outdoor public places? French Health and Family Minister Catherine Vautrin explained in an interview published by the regional Ouest-France daily on its website that tobacco 'must disappear where there are children.' She added, 'The decision is rooted in public health, particularly for children. The freedom to smoke stops where children's right to breathe clean air starts.' The restrictions will take effect on July 1 and will cover all outdoor areas where children are likely to be present, including beaches, parks, public gardens, school surroundings, bus stops, and sports venues, she said. According to Santé Publique France (Public Health France), the French national public health agency reporting to the Ministry of Health, about 75,000 people die from tobacco-related complications each year in the country. The government wants to take stronger steps to reduce this number and ensure that children are not exposed to secondhand smoke in open, public areas. Where will smoking be banned under the new rules? Public parks and gardens Beaches School surroundings Sports stadiums and grounds Bus and tram stops The aim is to create tobacco-free zones in all places where children and families gather. What is the penalty for breaking France's new smoking ban? If you're caught smoking in a restricted outdoor area, you could face a fine of up to €135 ($154). French authorities plan to actively enforce the new rules, with signage and public awareness campaigns to support compliance. Are there exceptions to the smoking ban in France? There are two notable exceptions: Café terraces are exempt, meaning adults can still smoke while sipping coffee outside a café Electronic cigarettes (e-cigarettes or vapes) are not included in this ban, though France is working on tightening vaping regulations soon Do French citizens support the outdoor smoking ban? According to a survey cited by news agency AFP, 62 per cent of French citizens support a ban on smoking in public spaces. That's nearly two out of three people. How widespread is smoking in France today? According to a report by the French Observatory of Drugs and Addictive Behaviours, a non-profit organisation that collects data on drug use and addiction and evaluates public policy, smoking is declining in the country, particularly among teens. It found that daily smoking among 17-year-olds has dropped by nearly 16 percentage points since 2011. However, vaping is becoming more common, with 56.9 per cent of 17-year-olds having tried it at least once. France joins global efforts to tighten tobacco laws France is joining a growing list of countries stepping up their tobacco control measures. Spain recently proposed expanding its own smoking bans to include terraces, university campuses, and open-air nightclubs. The UK is banning all single-use disposable vapes starting June 1 and is debating further restrictions on smoking in public spaces. For more health updates, follow #HealthWithBS

New WHO agreement on pandemic response: What's it is and what it will do
New WHO agreement on pandemic response: What's it is and what it will do

Business Standard

time21-05-2025

  • Health
  • Business Standard

New WHO agreement on pandemic response: What's it is and what it will do

With lessons from Covid-19, WHO members back treaty to improve equity, vaccine access, and emergency coordination during future outbreaks Barkha Mathur New Delhi World Health Organization (WHO) member states have adopted a landmark agreement aimed at addressing the gaps exposed during the Covid-19 pandemic. The WHO Pandemic Agreement is designed to ensure faster, fairer and more coordinated global responses during future health emergencies. What is the WHO Pandemic Agreement? The WHO Pandemic Agreement is the first legally binding international accord to comprehensively address pandemic prevention, preparedness, and response. Adopted under Article 19 of the WHO Constitution, it promotes data sharing, equitable access to resources and greater cooperation between countries during health crises. The agreement text states that member countries recognise 'that the international spread of disease is a global threat… that calls for the widest possible international and regional collaboration… while reaffirming the principle of the sovereignty of States in addressing public health matters.' What are the goals of the WHO pandemic treaty? The agreement outlines five primary objectives: Ensure equitable access to pandemic-related vaccines, treatments, and diagnostics Strengthen collaboration through data and pathogen sharing Support resilient health systems, especially in low-resource settings Promote knowledge and technology transfer for local production Establish sustainable funding mechanisms for rapid response How will countries benefit from the pandemic agreement? Countries that sign and ratify the agreement will be entitled to: Rapid access to 20 per cent of global pandemic-related health product output — 10 per cent as donations, 10 per cent at affordable prices A Global Supply Chain and Logistics Network (GSCL) for fair resource distribution A coordinated financial mechanism for emergency response from day one of a pandemic Access to shared technologies and production knowledge, especially in developing countries What is the WHO Pathogen Access and Benefit-Sharing System (PABS)? The Pathogen Access and Benefit-Sharing System (PABS), still under negotiation, will govern how countries share biological materials and genome sequences and ensure fair return benefits like vaccines and diagnostics. The PABS annex will be finalised for consideration at the 2026 World Health Assembly. The treaty also adopts a 'One Health' approach, acknowledging the link between human, animal and environmental health. What happens next? The agreement is now open for signature and ratification. It will become binding once ratified by 60 countries. Member states are expected to: Begin aligning national laws with the agreement Engage in the development of the PABS annex Support WHO-led efforts to strengthen health systems, particularly in developing nations Consider early ratification to expedite the treaty's entry into force How will the agreement promote equity in vaccine distribution? The agreement directly addresses vaccine inequity, a major issue during the Covid-19 pandemic. Pharmaceutical manufacturers will be required to reserve: 10 per cent of production for WHO-led donations 10 per cent at reduced prices for distribution to low-income nations The agreement also discourages vaccine hoarding and promotes timely and transparent supply allocation to vulnerable populations. What did WHO say about the significance of the treaty? 'The world is safer today thanks to the leadership, collaboration and commitment of our Member States to adopt the historic WHO Pandemic Agreement,' said WHO Director-General Dr Tedros Adhanom Ghebreyesus in a statement. He added: 'The Agreement is a victory for public health, science and multilateral action. It will ensure we, collectively, can better protect the world from future pandemic threats. It is also a recognition by the international community that our citizens, societies and economies must not be left vulnerable to again suffer losses like those endured during Covid-19.'

Alzheimer's diagnosis with blood test becomes reality: All you need to know
Alzheimer's diagnosis with blood test becomes reality: All you need to know

Business Standard

time21-05-2025

  • Health
  • Business Standard

Alzheimer's diagnosis with blood test becomes reality: All you need to know

Lumipulse G pTau217/ß-Amyloid 1-42: USFDA has approved the first-ever blood test to help diagnose Alzheimer's disease, offering a faster, less invasive, and more affordable way to detect early signs Barkha Mathur New Delhi The US Food and Drug Administration (FDA) has approved the first-ever in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer's disease. Set to launch in June 2025, the test offers a faster, more accessible, and less invasive alternative to PET scans and spinal taps, especially for people showing early signs of memory loss and cognitive decline. It has been granted 'Breakthrough Device' designation by the FDA, reflecting its potential to significantly improve Alzheimer's detection and care. 'Alzheimer's disease impacts too many people, more than breast cancer and prostate cancer combined,' said FDA Commissioner Martin A Makary in a statement. 'Knowing that 10 per cent of people aged 65 and older have Alzheimer's, and that by 2050 that number is expected to double, I am hopeful that new medical products such as this one will help patients.' What is the Lumipulse blood test and how does it work? Developed by Fujirebio Diagnostics, the test is called the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. It measures the ratio of two key biomarkers in the blood—β-amyloid 1-42 and β-amyloid 1-40—both of which are linked to the buildup of amyloid plaques in the brain, a defining feature of Alzheimer's disease. Who can take Alzheimer's blood test and when should it be used? The test is intended for adults aged 55 and older who are showing early signs of cognitive decline, such as memory loss or confusion. It is not a screening tool for asymptomatic individuals and is not available over the counter. The FDA emphasised that the test should support, not replace, a doctor's clinical assessment. It requires a physician's referral and is not meant for standalone diagnosis. What are the current ways Alzheimer's is diagnosed? Traditional diagnostic methods include: Cognitive tests and memory assessments Brain scans such as MRI or PET Spinal taps for cerebrospinal fluid (CSF) analysis These tests can be costly, invasive, and are not always covered by insurance—especially in developing countries. How accurate is the Alzheimer's blood test compared to current diagnostic methods? In a clinical trial involving 499 patients, the test demonstrated high diagnostic reliability: 91.7 per cent of people with positive results had Alzheimer's-associated plaques confirmed by PET scans or spinal taps 97.3 per cent of those with negative results had no plaques This level of accuracy could significantly reduce the need for expensive and invasive PET imaging or lumbar punctures. When and where will the Alzheimer's test be available? Fujirebio has confirmed that the test will be available in certified laboratories across the United States starting June 2025. It will not be sold directly to consumers and will require a physician's order. How can this test impact Alzheimer's treatment? Early diagnosis allows earlier intervention, which is critical to slowing the progression of Alzheimer's disease. This test could help doctors identify candidates for drugs like Leqembi (lecanemab) and Kisunla (donanemab) before significant brain damage occurs. A positive test result indicates the presence of amyloid plaques but does not confirm Alzheimer's on its own. False positives and negatives are possible, and results must be interpreted alongside other clinical evaluations. Why this matters for Alzheirmer's patients and caregivers This new blood test marks a significant breakthrough in making Alzheimer's diagnosis more accessible and less burdensome. For families and patients, it could mean earlier answers, targeted treatments, and improved planning for the future. For more health updates, follow #HealthWithBS

Kusha Kapila gets invisible braces: Why clear aligners are trending now
Kusha Kapila gets invisible braces: Why clear aligners are trending now

Business Standard

time19-05-2025

  • Health
  • Business Standard

Kusha Kapila gets invisible braces: Why clear aligners are trending now

With Kusha Kapila joining the clear aligner crowd, this once-niche dental fix is now a mainstream must-have for millennials and professionals alike Barkha Mathur New Delhi Traditional metal braces that some of us were forced to wear in high school were never fun. Between the wires, food restrictions, and awkward grins in photos, while many accepted their fate, others just chose to live with imperfect teeth. But now, invisible aligners—a sleek new way to straighten teeth—have taken over urban India. From Instagram influencers to young professionals, everyone's hopping on this clear-tray trend. Recently, content creator and internet icon Kusha Kapila revealed she is on an invisible aligner journey, and soon her changed smile had everyone talking. View this post on Instagram A post shared by Invisalign India (@invisalign_in) How do clear aligners straighten your teeth? Invisible aligners are clear, removable trays that straighten teeth without metal braces. They use custom-made orthodontic moulds to fit snugly over your teeth and gradually shift them into alignment. They are typically worn for 20–22 hours a day and removed only for eating, drinking (except water), brushing, and flossing. They need to be changed every 1 week to 10 days, depending on the programme, to progress the treatment. Technology behind invisible braces: CAD, 3D scans and more According to California-based Align Technology, which manufactures Invisalign clear aligners, the tech used includes 3D scans, computer-aided design (CAD), computer-aided manufacturing (CAM), and thermoformed plastic trays. What materials are used in invisible aligners? The materials vary by brand but generally include: Medical-grade thermoplastic polymers for strength and flexibility SmartTrack material (Invisalign) for controlled tooth movements BPA-free polyurethane resins (ClearCorrect) ClearQuartz (ClearCorrect), offering improved elasticity and force consistency Why are invisible braces becoming popular in India? Aesthetic preference: Millennials and professionals want straight teeth without visible braces Digital access: Teledentistry and apps make it easier to track progress Health and confidence trends: A perfect smile is now part of wellness culture Celebrity endorsements: Influencers and actors are marketing clear aligners Convenience: Fewer clinic visits and minimal lifestyle disruption Which invisible aligner brands are available in India? Toothsi/makeO: ₹50,000 – ₹90,000, home scans, D2C model Illusion Aligners: ₹40,000 – ₹1.2 lakh, 3D tech, global certifications Clove Dental: ₹49,999 onwards, includes both Invisalign and in-house aligners 32 Watts Clear Aligners: ₹40,000 – ₹1 lakh, app tracking Flash Aligners: In-clinic only, strong presence in smaller cities How to get started with invisible aligners in India Option A: Direct-to-consumer (D2C) like Toothsi/makeO Book free home scan or impression kit Receive a 3D smile preview Approve treatment, pay (EMI available) Get aligners delivered home Monitor via app or dentist check-ins Option B: In-clinic route (e.g., Invisalign, Clove Dental) Visit certified orthodontist Get 3D scans and customised treatment Receive aligners and attend regular follow-ups What are the pros and cons of invisible aligners? Pros: Virtually invisible Removable during meals No wires or brackets Fewer dentist visits Comfortable and custom-fit Cons: Must wear ~22 hrs/day Not suitable for complex dental issues Costlier than metal braces in some cases Are clear aligners worth the cost and hype? According to Clove Dental, invisible aligners are a great fit if aesthetics and comfort are priorities. They're especially suitable for influencers, working professionals, and anyone seeking discreet orthodontic treatment. However, they're not a substitute for traditional braces in complex orthodontic cases.

World Asthma Day 2025: Theme, treatment, and tips for better care
World Asthma Day 2025: Theme, treatment, and tips for better care

Business Standard

time06-05-2025

  • Health
  • Business Standard

World Asthma Day 2025: Theme, treatment, and tips for better care

Observed globally on May 6, this year's asthma day stresses better access to inhalers, expert-backed prevention, and early diagnosis to reduce global health burden Barkha Mathur New Delhi For the millions living with asthma, the simple act of breathing can be a daily challenge. World Asthma Day 2025, on Tuesday, is a global reminder of the importance of respiratory health and the urgent need to make asthma care accessible to everyone. Whether you live with asthma, care for someone who does, or simply want to learn more, this day puts the spotlight on equitable treatment and empowering communities to take control of their health. What is World Asthma Day and why is it observed globally? World Asthma Day is observed annually on the first Tuesday of May to raise awareness about asthma, a chronic respiratory condition that affects millions of people globally. This year, it falls on May 6. Organised by the Global Initiative for Asthma (GINA), the day highlights the urgent need for accessible, equitable, and effective asthma treatment worldwide. Key asthma symptoms: What to watch for and when to seek help According to the World Health Organization (WHO), asthma is a chronic inflammatory disease of the airways that leads to recurring episodes of breathlessness, wheezing, chest tightness, and coughing. It can vary in severity and frequency, and often worsens during the night or early morning. WHO says the symptoms of asthma can vary from person to person and can sometimes get significantly worse. This is known as an asthma attack. Symptoms are often worse at night or during exercise. Common symptoms of asthma include: A persistent cough, especially at night Wheezing when exhaling and sometimes when inhaling Shortness of breath or difficulty breathing, sometimes even when resting Chest tightness, making it difficult to breathe deeply According to the WHO, over 260 million people are affected by asthma worldwide, and it remains one of the leading causes of non-communicable disease-related deaths, especially in children. Acute vs chronic asthma: Understanding the difference for better care Understanding the types of asthma is crucial for effective treatment. Acute asthma involves sudden and severe airway obstruction, often triggered by infections, allergens, cold air, or stress. It requires immediate intervention to prevent complications. Chronic asthma, on the other hand, is marked by long-standing inflammation and ongoing sensitivity to environmental triggers like dust, smoke, and air pollution. As Dr Anshula Tayal Bansal, Consultant – Paediatric Pulmonology & Intensive Care at Manipal Hospital Goa, explains, 'An understanding of acute and chronic asthma is important for timely and successful intervention in the treatment of a chronic inflammatory disease of the airways, known as asthma, with episodes of acute, reversible airway obstruction.' She underscores the need for accurate diagnosis and personalised care strategies for each type of asthma, especially as unmanaged chronic asthma can lead to irreversible changes in lung function. What causes asthma? Top risk factors you should know Asthma is a complex condition with no single, definitive cause. However, according to WHO, several risk factors have been identified that increase a person's likelihood of developing it: Family history and genetics: Having a close relative with asthma—such as a parent or sibling—significantly raises the risk Allergic conditions: Individuals with conditions like eczema or allergic rhinitis are more likely to develop asthma Urban lifestyle and pollution: Air pollution and limited green spaces contribute to higher asthma rates in urban areas Early life influences: Factors like premature birth, low birth weight, and early respiratory infections increase risk Environmental irritants: Exposure to dust, mould, fumes, and chemicals can worsen symptoms Obesity: Excess weight influences lung function and inflammation, raising asthma risk How to manage asthma: Doctor-recommended tips for symptom control Managing asthma effectively, especially during the warmer months and high-pollution periods, requires both preventive and reactive strategies. Here are expert-recommended tips to help manage symptoms and reduce the risk of attacks: Schedule outdoor activities early in the day when pollution and pollen levels are lower Consult your pulmonologist regularly to adjust medications based on seasonal or lifestyle changes Store inhalers in a cool, shaded place to maintain their efficacy Take controller medications as prescribed, and always keep a rescue inhaler handy Stay hydrated to help thin mucus and ease breathing Monitor local weather and air quality reports, especially during high-smog days Use High-Efficiency Particulate Air (HEPA) filters or air purifiers at home to minimise exposure to allergens and pollutants Why World Asthma Day matters: Global awareness and impact since 1998 World Asthma Day was first held in 1998, with participation from over 35 countries in the first World Asthma Meeting in Barcelona, Spain. It was initiated by GINA to enhance asthma awareness and education globally. Over the years, the day has become a crucial annual event aimed at: Educating the public and patients about asthma Promoting preventive measures and effective treatment Reducing stigma and misinformation Encouraging governments and stakeholders to prioritise asthma care in health policies World Asthma Day 2025 theme: Make inhaled treatments accessible for all This year's theme, 'Make Inhaled Treatments Accessible for ALL', emphasises the need to ensure that essential asthma medications such as inhaled corticosteroids and reliever inhalers are affordable and widely available, especially in low- and middle-income countries (LMICs). Inhaled treatments are crucial for both daily symptom control and emergency relief. Yet, millions around the world lack access due to economic, geographic, and systemic healthcare barriers. The 2025 theme calls on governments, pharmaceutical companies, and international health bodies to improve supply chains, reduce costs, and promote equitable distribution of these life-saving treatments. World Asthma Day initiatives: Awareness, screenings, and community action World Asthma Day sees a wide range of community outreach efforts, including: Free health screenings and lung function tests Public awareness campaigns in schools, workplaces, and public spaces Workshops and webinars by healthcare professionals Social media drives to spread accurate information and support networks These initiatives aim to empower individuals with knowledge about early symptoms, the importance of regular check-ups, and the availability of effective treatments.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store